157 related articles for article (PubMed ID: 12036913)
41. [Analysis of polymorphisms in genes of insulin receptor substrate-1 and enzymes involved in estrogen biosynthesis and metabolism among breast cancer patients with BRCA1 mutations].
Bershteĭn LM; Ulybina IuM; Pozharisskiĭ KM; Imianitov EN
Vopr Onkol; 2009; 55(2):158-64. PubMed ID: 19514368
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
Auranen A; Song H; Waterfall C; Dicioccio RA; Kuschel B; Kjaer SK; Hogdall E; Hogdall C; Stratton J; Whittemore AS; Easton DF; Ponder BA; Novik KL; Dunning AM; Gayther S; Pharoah PD
Int J Cancer; 2005 Nov; 117(4):611-8. PubMed ID: 15924337
[TBL] [Abstract][Full Text] [Related]
43. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
[TBL] [Abstract][Full Text] [Related]
44. BRCA1: what do we know? What do we think we know? What do we really need to know?
Buller RE
Gynecol Oncol; 2000 Mar; 76(3):291-3. PubMed ID: 10684698
[No Abstract] [Full Text] [Related]
45. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
Antoniou AC; Sinilnikova OM; Simard J; Léoné M; Dumont M; Neuhausen SL; Struewing JP; Stoppa-Lyonnet D; Barjhoux L; Hughes DJ; Coupier I; Belotti M; Lasset C; Bonadona V; Bignon YJ; ; Rebbeck TR; Wagner T; Lynch HT; Domchek SM; Nathanson KL; Garber JE; Weitzel J; Narod SA; Tomlinson G; Olopade OI; Godwin A; Isaacs C; Jakubowska A; Lubinski J; Gronwald J; Górski B; Byrski T; Huzarski T; Peock S; Cook M; Baynes C; Murray A; Rogers M; Daly PA; Dorkins H; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Niederacher D; Deissler H; ; Spurdle AB; Chen X; Waddell N; Cloonan N; ; Kirchhoff T; Offit K; Friedman E; Kaufmann B; Laitman Y; Galore G; Rennert G; Lejbkowicz F; Raskin L; Andrulis IL; Ilyushik E; Ozcelik H; Devilee P; Vreeswijk MP; Greene MH; Prindiville SA; Osorio A; Benitez J; Zikan M; Szabo CI; Kilpivaara O; Nevanlinna H; Hamann U; Durocher F; Arason A; Couch FJ; Easton DF; Chenevix-Trench G;
Am J Hum Genet; 2007 Dec; 81(6):1186-200. PubMed ID: 17999359
[TBL] [Abstract][Full Text] [Related]
46. Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy.
Nogueira A; Catarino R; Faustino I; Nogueira-Silva C; Figueiredo T; Lombo L; Hilário-Silva I; Pereira D; Medeiros R
Gene; 2012 Aug; 504(2):279-83. PubMed ID: 22634097
[TBL] [Abstract][Full Text] [Related]
47. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Lee HB; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
Breast Cancer Res Treat; 2019 May; 175(1):117-127. PubMed ID: 30671767
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.
Lee KM; Choi JY; Kang C; Kang CP; Park SK; Cho H; Cho DY; Yoo KY; Noh DY; Ahn SH; Park CG; Wei Q; Kang D
Clin Cancer Res; 2005 Jun; 11(12):4620-6. PubMed ID: 15958648
[TBL] [Abstract][Full Text] [Related]
49. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
50. BRCA gene structure and function in tumor suppression: a repair-centric perspective.
Murphy CG; Moynahan ME
Cancer J; 2010; 16(1):39-47. PubMed ID: 20164689
[TBL] [Abstract][Full Text] [Related]
51. CHEKs and balances: accounting for breast cancer.
Brody LC
Nat Genet; 2002 May; 31(1):3-4. PubMed ID: 11984555
[No Abstract] [Full Text] [Related]
52. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
Maxwell CA; Benítez J; Gómez-Baldó L; Osorio A; Bonifaci N; Fernández-Ramires R; Costes SV; Guinó E; Chen H; Evans GJ; Mohan P; Català I; Petit A; Aguilar H; Villanueva A; Aytes A; Serra-Musach J; Rennert G; Lejbkowicz F; Peterlongo P; Manoukian S; Peissel B; Ripamonti CB; Bonanni B; Viel A; Allavena A; Bernard L; Radice P; Friedman E; Kaufman B; Laitman Y; Dubrovsky M; Milgrom R; Jakubowska A; Cybulski C; Gorski B; Jaworska K; Durda K; Sukiennicki G; Lubiński J; Shugart YY; Domchek SM; Letrero R; Weber BL; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; Roozendaal CE; ; ; Easton DF; Peock S; Cook M; Oliver C; Frost D; Harrington P; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Eccles D; Douglas F; Brewer C; Nevanlinna H; Heikkinen T; Couch FJ; Lindor NM; Wang X; Godwin AK; Caligo MA; Lombardi G; Loman N; Karlsson P; Ehrencrona H; Wachenfeldt Av; ; Barkardottir RB; Hamann U; Rashid MU; Lasa A; Caldés T; Andrés R; Schmitt M; Assmann V; Stevens K; Offit K; Curado J; Tilgner H; Guigó R; Aiza G; Brunet J; Castellsagué J; Martrat G; Urruticoechea A; Blanco I; Tihomirova L; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; Schmutzler RK; Wappenschmidt B; Meindl A; Arnold N; Deissler H; Varon-Mateeva R; Sutter C; Niederacher D; Imyamitov E; Sinilnikova OM; Stoppa-Lyonne D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Fert Ferrer S; Collonge-Rame MA; Mortemousque I; ; Spurdle AB; Beesley J; Chen X; Healey S; ; Barcellos-Hoff MH; Vidal M; Gruber SB; Lázaro C; Capellá G; McGuffog L; Nathanson KL; Antoniou AC; Chenevix-Trench G; Fleisch MC; Moreno V; Pujana MA
PLoS Biol; 2011 Nov; 9(11):e1001199. PubMed ID: 22110403
[TBL] [Abstract][Full Text] [Related]
53. Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer.
van Verschuer VM; Hooning MJ; van Baare-Georgieva RD; Hollestelle A; Timmermans AM; Koppert LB; Verhoog LC; Martens JW; Seynaeve C; van Deurzen CH
Hum Pathol; 2015 Feb; 46(2):182-90. PubMed ID: 25522926
[TBL] [Abstract][Full Text] [Related]
54. The effect of genetic variability on drug response in conventional breast cancer treatment.
Wiechec E; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):122-30. PubMed ID: 19836373
[TBL] [Abstract][Full Text] [Related]
55. Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis.
Wu L; Wang F; Xu R; Zhang S; Peng X; Feng Y; Wang J; Lu C
Breast Cancer Res Treat; 2013 Dec; 142(3):619-27. PubMed ID: 24258259
[TBL] [Abstract][Full Text] [Related]
56. ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival.
Kauppinen JM; Kosma VM; Soini Y; Sironen R; Nissinen M; Nykopp TK; Kärjä V; Eskelinen M; Kataja V; Mannermaa A
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2133-42. PubMed ID: 20716618
[TBL] [Abstract][Full Text] [Related]
57. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
58. Carcinogen-induced DNA double strand break repair in sporadic breast cancer.
Zhang C; Naftalis E; Euhus D
J Surg Res; 2006 Sep; 135(1):120-8. PubMed ID: 16650867
[TBL] [Abstract][Full Text] [Related]
59. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
Azzato EM; Driver KE; Lesueur F; Shah M; Greenberg D; Easton DF; Teschendorff AE; Caldas C; Caporaso NE; Pharoah PD
Breast Cancer Res; 2008; 10(3):R47. PubMed ID: 18507837
[TBL] [Abstract][Full Text] [Related]
60. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population.
Zhu Y; Zhai K; Ke J; Li J; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Gong J; Zhong R; Huang K; Chang J; Miao X
Oncotarget; 2017 May; 8(22):36033-36039. PubMed ID: 28415599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
